So just to temper enthusiasm I expect we will get the results in early 2027 so approval at the earliest will be in 2028! |
This is excellent news. Today should see some significant upside. |
So the dosing is ‘at much higher concentrations’; than before! If only the company had listened to me all those years ago when I told them their own data indicated they needed a much higher concentration. The stick I got from some aggressive BB posters was appalling including one who threatened to come round to my house and sort me out!
Indeed I wonder if the FDA’s change in stance was down to me. Around 3 years ago I sent an email containing all the documentary evidence to the FDA. I just got a standard reply so of course don’t know if anyone took notice of it but in the interim they completely changed their position.
Anyway shareholders should rightly hold McCarthy to account because he was the Chairman at the time….. |
It has been said 'no news is good news'; not sure this is true for IMM but as usual it is wait and see. |
Still no news and share price drifts ...really not sure if i should just get out now |
zilch - it'll be RNS'd. And you can bet your bottom dollar this board will then immediately be drowned in commentary (most of it irrational). |
any news from the FDA Meeting last week ? |
Probably 'cos some expected an RNS the day after their scheduled FDA meeting. To be fair to Tim (& I rarely am, 'cos he's useless), he did say those meeting dates were only estimates and that things could slide. And we're quite used to things sliding at IMM (mainly the share price). |
Clearly not good as price is going down..but why if no info??? |
No RNS yet = no update. |
Has there been any update on the meeting due to take place yesterday |
Bring on June 7th ----------- Lupazor phase 3 FDA approval meeting
If that is positive ........watch this FLY
More than Fingers Crossed for everyone |
LLOL-see what passes for analysis from him on LSE and weep. |
I see Aridis Pharmaceuticals Inc were up over 170% today - must be to do with this ......
"Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the FDA on the Company’s proposed single confirmatory Phase 3 study of investigational monoclonal antibody candidate AR-301 ......" |
I've already learnt something, but many thanks for the thought LLOL |
clintdavid1 - yes, then stockriser might actually learn something. |
You should see what LLOL passes off as analysis! |
You're very welcome LLOL |
Stockriser - thanks for that detailed analysis. |
Blue today me thinks ;-)
GLA SR |
JUNE 7TH DECISION FDA LUPIZOR PHASE 3 TRIALS UNLOCKING $25M AND 70M ROYAL BACK ROYALTIES |
june 7th key Lupazor phase 3 FDA approval meeting which unlocks $25m of funding from Avion and $70m in Royalties in a $10bn Lupus market!!
serious chance of a multibagger here gla |
bouncer
Posts: 20,586
Price: 3.07
Strong Buy
The appetiserToday 07:58
The massive news comes June 7/8th |
Better news than expected. Can see this trading closer to 5p |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
